Alzheimer's Disease Market

View All

leqembi-for-alzheimers-disease-treatment
Leqembi: A New Hope for Alzheimer’s Disease Patients

Alzheimer’s disease is the most common type of dementia, accounting for more than 60% of all cases, and is characterized by a gradual decline in cognitive and functional abilities. It represents a global health crisis that is increasing with the increasing geriatric population. It represents a global health crisis ...

Find More

donanemab-for-alzheimers-disease-treatment
The Road Ahead for Donanemab: Will the Therapy be the Next Imminent Breakthrough in the Alzheimer’s Disease Treatment Landscape?

Alzheimer’s disease (AD) is becoming a rapidly growing public health concern due to the rise in the world’s aging population. Based on the data obtained from the 2019 Global Burden of Disease (GBD) database, the incidence and prevalence of Alzheimer’s disease and other dementias increased by 147.95 and 160.84%, res...

Find More

marijuana-to-treat-Alzheimer's
Can Alzheimer’s be cured with Marijuana?

Alzheimer's is a progressive brain disorder that results in the degeneration of brain cells. It affects the thinking, reasoning, memory, and problem-solving skills of the person. Apart from cognitive function, it also influences mood, personality, behavior, and social skills. In the advanced stages, the patients ar...

Find More

Alzheimer-Disease-Risk-Factors
The Question That Remains Unanswered: What Might Be Causing Alzheimer’s?

50 million people globally have dementia, and out of all the dementia cases, Alzheimer’s Disease accounts for about 60–70% of cases, says the WHO. Alzheimer's Disease is a neurodegenerative disease, a common cause of dementia that affects behavior, memory, and thinking abilities of an individual. Mostly the symptom...

Find More

Alzheimer’s Disease Market | Biogen | Aducanumab | Eisai| Biogen | Aducanumab | Eisai |
Can Aducanumab Solve the Puzzle Of Alzheimer’s?

Alzheimer's Disease Market finally witnessed the approval of standard therapy, Aducanumab, by Biogen. What impact does it hold for the future? Demographic or population ageing is a global and dominant phenomenon of the 21st century. Different geographies are experiencing population ageing at different rates. As ...

Find More

Alzheimer’s-Disease-Market-Scenario
An Ageing Population and Upcoming Therapies: What is shaping the Alzheimer’s Disease Market Scenario?

The ageing population is a global phenomenon. According to the UN’s “World Population Prospects 2019” by 2100, the world’s population is projected to reach approximately 10.9 billion. Moreover, between 2020 and 2100, the number of people ages 80 and older is expected to increase from 146 million to 881 million. ...

Find More

Alzheimer's Disease Market Infographic
Alzheimer’s Disease Market Infographic

Alzheimer's Disease Market Infographic It's is the end of Alzheimer's Awareness Month, but our hope for a cure for this disease will not end. They may not remember us, but we need to remember that Alzheimer's battle is not theirs alone, but all of ours.

Find More

Alzheimer
World Alzheimer’s Day

World Alzheimer’s Day World Alzheimer’s Day takes place on 21 September of every year. World Alzheimer's Day is a campaign to raise awareness and highlight issues faced by people those who are affected by dementia. The exact cause of Alzheimer's disease is not known, although several things are considered to ...

Find More

alzheimer and menopause
What is the link between Alzheimer’s and Menopause?

Alzheimer is known to affect an estimated 50 million people worldwide. There is no doubt that this number is going to reach 75 million in 2030 and 131.5 million in 2050 of all age group worldwide. Among affected 5.5 million people aged 65 and older with Alzheimer's in the United States, 3.4 million were reported wo...

Find More

Alzheimer’s drug fails! Is it time to move on?

Alzheimer’s is one of the diseases which are irreversible and untreatable. With causes still unknown adds to the further conundrum.  But for more than two decades now Scientists from everywhere have been working on the “amyloid hypothesis". It has been a long-standing theory that brains of the people affected ...

Find More